Inhibition of vaccinia virus replication by canavanine and canaline.
D000596:Amino Acids / Q000378:metabolism; D001120:Arginine / Q000494:pharmacology; D002172:Canavanine / Q000494:pharmacology*; D002250:Carbon Radioisotopes; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003864:Depression, Chemical; D006367:HeLa Cells / Q000378:metabolism; D006801:Humans; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009952:Ornithine / Q000031:analogs & derivatives* / Q000494:pharmacology; D011732:Pyridoxal Phosphate / Q000494:pharmacology; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013237:Stereoisomerism; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014529:Uridine / Q000378:metabolism; D014616:Vaccinia virus / Q000254:growth & development*; D014779:Virus Replication / Q000187:drug effects*
D000596:Amino Acids; D002250:Carbon Radioisotopes; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D014316:Tritium; D002172:Canavanine; D011732:Pyridoxal Phosphate; D001120:Arginine; D009952:Ornithine; D013936:Thymidine; D014529:Uridine